DRKS00033444招募中不适用
VALIdation of a Treatment Decision Pathway for Andexanet Alfa - VALIDA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- GWT-TUD GmbH
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •2) objectively confirmed acute and life-threating emergency in patients reported to be taking dXI
- •at least 80% of the emergencies included need to be bleeding emergencies
- •up to 20% of patients with emergency surgery are allowed
- •3) availability of specific and calibrated anti-Xa levels from blood samples obtained within 6 hours after admission AND obtained before reversal with Andexanet Alfa (if used)
- •4) availability of routine blood tests (blood count, eGFR, aPTT, prothrombin time, INR) from blood samples obtained within 90 minutes after admission
排除标准
- •patients not fulfilling inclusion criteria
研究者
相似试验
招募中
4 期
THE DECIDE-TB TRIATuberculosisPACTR202407866544155niversity of Zambia School of Medicine30,240
招募中
不适用
Evaluation of suitable criteria for the therapy of uterine fibroids by MR-guided high-intensity focused ultrasound (MR-HIFU)D25.0D25.1Submucous leiomyoma of uterusIntramural leiomyoma of uterusDRKS00013526Klinikum der Universität München, Campus Großhadern75
招募中
1 期
Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among childreIRCT20180519039715N3Kermanshah University of Medical Sciences188
尚未招募
不适用
Developing a integrative clinical subtype and treatment model by identifying the common and differential mechanisms of cognitive dysfunction and depression.Mental and behavioural disordersKCT0007319Hallym University Medical Center- Chuncheon500
已完成
不适用
Validation of "Clinical evaluation methods for new antibacterial drugs to treat respiratory infections" (second version)Community-acquired bacterial pneumoniaJPRN-UMIN000004831agasaki evaluation organization for clinical interventions75